Form 4 for BNTC Benitec Biopharma Inc.

Accepted 2024-12-26 00:00:00 ET · period of report 2024-12-23 · accession 0000899140-24-001385 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2024-12-26	2024-12-23+	BNTC	Cowen Aaron	10%	P - Purchase	$11.09	+47.5K	958.3K	+5%	+$527.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common stock, par value $0.0001 per share	2024-12-24	P	A	2,288	$11.25	960,554	I See footnotes	—	—	(F5) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
2	Common	Common stock, par value $0.0001 per share	2024-12-24	P	A	17,730	$11.25	7,999,455	I See footnotes	—	—	(F4) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
3	Common	Common stock, par value $0.0001 per share	2024-12-23	P	A	24,360	$10.98	7,981,725	I See footnotes	—	—	(F2) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
4	Common	Common stock, par value $0.0001 per share	2024-12-23	P	A	3,142	$10.98	958,266	I See footnotes	—	—	(F3) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.